Disease, therapy, and previous alloimmunization exposure of patients receiving platelet transfusions for thrombocytopenia
| . | Treatment group, no. (%) . | |
|---|---|---|
| Test (n = 52) . | Reference (n = 51) . | |
| Primary diagnosis | ||
| Acute leukemia | 26 (50) | 24 (47) |
| Hematopoietic tumor*/nonhematopoietic solid tumor | 21 (40) | 19 (37) |
| Other | 5 (10) | 8 (16) |
| Therapy | ||
| Bone marrow transplantation | 2 (4) | 1 (2) |
| Peripheral blood stem cell transplantation | 17 (33) | 18 (35) |
| Chemotherapy | 33 (63) | 32 (63) |
| Alloimmunization exposure† | 46 (88) | 44 (86) |
| . | Treatment group, no. (%) . | |
|---|---|---|
| Test (n = 52) . | Reference (n = 51) . | |
| Primary diagnosis | ||
| Acute leukemia | 26 (50) | 24 (47) |
| Hematopoietic tumor*/nonhematopoietic solid tumor | 21 (40) | 19 (37) |
| Other | 5 (10) | 8 (16) |
| Therapy | ||
| Bone marrow transplantation | 2 (4) | 1 (2) |
| Peripheral blood stem cell transplantation | 17 (33) | 18 (35) |
| Chemotherapy | 33 (63) | 32 (63) |
| Alloimmunization exposure† | 46 (88) | 44 (86) |